{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:57:36Z","timestamp":1781067456937,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16137-5","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:06:40Z","timestamp":1780999600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of NFS1 and downregulation of GSDMD as prognostic biomarkers in acute myeloid leukemia: implications for diagnosis and therapeutic strategies"],"prefix":"10.1186","volume":"26","author":[{"given":"Sara M.","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.","family":"Elghobary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam R.","family":"Elghamry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"2","key":"16137_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41571-025-01099-7","volume":"23","author":"F El Chaer","year":"2026","unstructured":"El Chaer F, Bewersdorf JP, Stahl M, Zeidan AM. The global epidemiology of acute myeloid leukaemia. Nat Reviews Clin Oncol. 2026;23(2):107\u201320.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"8","key":"16137_CR2","first-page":"1037","volume":"137","author":"S Willier","year":"2021","unstructured":"Willier S, Roth\u00e4mel P, Hastreiter M, Wilhelm J, Stenger D, Blaeschke F, et al. CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy. Blood J Am Soc Hematol. 2021;137(8):1037\u201349.","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"16137_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2014-10-551911","volume":"126","author":"F Thol","year":"2015","unstructured":"Thol F, Schlenk RF, Heuser M, Ganser A. How I treat refractory and early relapsed acute myeloid leukemia. Blood. 2015;126(3):319\u201327.","journal-title":"Blood"},{"key":"16137_CR4","doi-asserted-by":"crossref","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","DOI":"10.1136\/bmj.n2026"},{"issue":"3","key":"16137_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood.2021011304","volume":"139","author":"E Estey","year":"2022","unstructured":"Estey E, Hasserjian RP, D\u00f6hner H. Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal. Blood. 2022;139(3):323\u201332.","journal-title":"Blood"},{"issue":"1","key":"16137_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"16137_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.bbrc.2019.06.070","volume":"516","author":"H-Y Zhu","year":"2019","unstructured":"Zhu H-Y, Huang Z-X, Chen G-Q, Sheng F, Zheng Y-S. Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy. Biochem Biophys Res Commun. 2019;516(4):1265\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"16137_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/bjc.2017.281","volume":"117","author":"PA Cassier","year":"2017","unstructured":"Cassier PA, Castets M, Belhabri A, Vey N. Targeting apoptosis in acute myeloid leukaemia. Br J Cancer. 2017;117(8):1089\u201398.","journal-title":"Br J Cancer"},{"issue":"4","key":"16137_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ccell.2017.09.001","volume":"32","author":"DE Reyna","year":"2017","unstructured":"Reyna DE, Garner TP, Lopez A, Kopp F, Choudhary GS, Sridharan A, et al. Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 2017;32(4):490\u2013e50510.","journal-title":"Cancer Cell"},{"issue":"34","key":"16137_CR10","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25(34):4798\u2013811.","journal-title":"Oncogene"},{"issue":"1","key":"16137_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.13872","volume":"96","author":"SM Radwan","year":"2020","unstructured":"Radwan SM, Elleboudy NS, Nabih NA, Kamal AM. The immune checkpoints Cytotoxic T lymphocyte antigen-4 and Lymphocyte activation gene-3 expression is up-regulated in acute myeloid leukemia. HLA. 2020;96(1):3\u201312.","journal-title":"HLA"},{"issue":"5","key":"16137_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"4","key":"16137_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"16137_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"6","key":"16137_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Berghe TV. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"7","key":"16137_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16137_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41575-023-00743-w","volume":"20","author":"G Privitera","year":"2023","unstructured":"Privitera G, Rana N, Armuzzi A, Pizarro TT. The gasdermin protein family: emerging roles in gastrointestinal health and disease. Nat Reviews Gastroenterol Hepatol. 2023;20(6):366\u201387.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"7","key":"16137_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"16137_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","volume":"26","author":"D Frank","year":"2019","unstructured":"Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99\u2013114.","journal-title":"Cell Death Differ"},{"key":"16137_CR20","doi-asserted-by":"publisher","first-page":"108802","DOI":"10.1016\/j.intimp.2022.108802","volume":"108","author":"R Shao","year":"2022","unstructured":"Shao R, Wang H, Wang J, Lu S, He R, Lu Y. Comprehensive analysis of a pyroptosis-related gene signature of clinical and biological value in acute myeloid leukaemia. Int Immunopharmacol. 2022;108:108802.","journal-title":"Int Immunopharmacol"},{"key":"16137_CR21","doi-asserted-by":"crossref","unstructured":"Yang X, Tang Z. Role of gasdermin family proteins in cancers (Review). Int J Oncol. 2023;63(3):100.","DOI":"10.3892\/ijo.2023.5548"},{"issue":"10","key":"16137_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11864-023-01119-7","volume":"24","author":"T Lyu","year":"2023","unstructured":"Lyu T, Yin Q. Research Progress on Pyroptosis in Hematological Malignancies. Curr Treat Options Oncol. 2023;24(10):1439\u201350.","journal-title":"Curr Treat Options Oncol"},{"issue":"20","key":"16137_CR23","first-page":"2391","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood J Am Soc Hematol. 2016;127(20):2391\u2013405.","journal-title":"Blood J Am Soc Hematol"},{"issue":"7","key":"16137_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, et al. Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw J Natl Compr Canc Netw. 2017;15(7):926\u201357.","journal-title":"J Natl Compr Cancer Netw J Natl Compr Canc Netw"},{"issue":"2","key":"16137_CR25","first-page":"39","volume":"3","author":"R Nunez","year":"2001","unstructured":"Nunez R. Flow cytometry: principles and instrumentation. Curr Issues Mol Biol. 2001;3(2):39\u201345.","journal-title":"Curr Issues Mol Biol"},{"key":"16137_CR26","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1200\/JCO.2002.08.155","volume":"20","author":"S Fr\u00f6hling","year":"2002","unstructured":"Fr\u00f6hling S, Skelin S, Liebisch C, Scholl C, Schlenk R, D\u00f6hner H, et al. Ulm. Detection of Chromosome Abnormalities in 240 consecutive Adult Patients with Acute Myeloid Leukemia. J Clin Oncol. 2002;20:2480\u20135.","journal-title":"J Clin Oncol"},{"issue":"4","key":"16137_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"4","key":"16137_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ol.2021.12587","volume":"21","author":"AM Kamal","year":"2021","unstructured":"Kamal AM, Nabih NA, Elleboudy NS, Radwan SM. Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome. Oncol Lett. 2021;21(4):325.","journal-title":"Oncol Lett"},{"issue":"7","key":"16137_CR29","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441\u2013e.","journal-title":"Blood Cancer J"},{"issue":"13","key":"16137_CR30","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.7150\/ijbs.45050","volume":"16","author":"J-y Liang","year":"2020","unstructured":"Liang J-y, Wang D-s, Lin H-c, Chen X-x, Yang H, Zheng Y, et al. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Int J Biol Sci. 2020;16(13):2430\u201341.","journal-title":"Int J Biol Sci"},{"key":"16137_CR31","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Front Cell Dev Biology. 2020;8:596679.","DOI":"10.3389\/fcell.2020.596679"},{"issue":"12","key":"16137_CR32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2217\/fon-2020-1113","volume":"17","author":"X Gao","year":"2021","unstructured":"Gao X, Tang M, Tian S, Li J, Liu W. A Ferroptosis-Related Gene Signature Predicts Overall Survival in Patients with Lung Adenocarcinoma. Future Oncol. 2021;17(12):1533\u201344.","journal-title":"Future Oncol"},{"key":"16137_CR33","doi-asserted-by":"publisher","first-page":"6687391","DOI":"10.1155\/2021\/6687391","volume":"2021","author":"L Yang","year":"2021","unstructured":"Yang L, Tian S, Chen Y, Miao C, Zhao Y, Wang R, et al. Ferroptosis-Related Gene Model to Predict Overall Survival of Ovarian Carcinoma. J Oncol. 2021;2021:6687391.","journal-title":"J Oncol"},{"issue":"2","key":"16137_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/diagnostics11020219","volume":"11","author":"H Luo","year":"2021","unstructured":"Luo H, Ma C. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma. Diagnostics. 2021;11(2):219.","journal-title":"Diagnostics"},{"issue":"2","key":"16137_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1080\/21655979.2021.2017627","volume":"13","author":"S Du","year":"2022","unstructured":"Du S, Zeng F, Sun H, Liu Y, Han P, Zhang B, et al. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Bioengineered. 2022;13(2):2498\u2013512.","journal-title":"Bioengineered"},{"issue":"1","key":"16137_CR36","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1080\/21655979.2021.1935400","volume":"12","author":"X Qian","year":"2021","unstructured":"Qian X, Tang J, Li L, Chen Z, Chen L, Chu Y. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma. Bioengineered. 2021;12(1):2341\u201351.","journal-title":"Bioengineered"},{"issue":"1","key":"16137_CR37","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1080\/21655979.2021.1925003","volume":"12","author":"X Qi","year":"2021","unstructured":"Qi X, Fu Y, Sheng J, Zhang M, Zhang M, Wang Y, et al. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer. Bioengineered. 2021;12(1):1813\u201325.","journal-title":"Bioengineered"},{"key":"16137_CR38","first-page":"e921947","volume":"26","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu Z, Jin T, Xu K, Liu M, Xu H. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis. Med Sci Monit. 2020;26:e921947.","journal-title":"Med Sci Monit"},{"key":"16137_CR39","doi-asserted-by":"crossref","unstructured":"Zhuo S, Chen Z, Yang Y, Zhang J, Tang J, Yang K. Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma. Front Oncol. 2020;10:590861.","DOI":"10.3389\/fonc.2020.590861"},{"key":"16137_CR40","doi-asserted-by":"crossref","unstructured":"Yun D, Wang X, Wang W, Ren X, Li J, Wang X et al. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma. Front Oncol. 2022;12:897702.","DOI":"10.3389\/fonc.2022.897702"},{"key":"16137_CR41","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1016\/j.csbj.2022.09.037","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Chen C, Geng R, Shao F, Yang S, Zhong Z, et al. Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer. Comput Struct Biotechnol J. 2022;20:5440\u201352.","journal-title":"Comput Struct Biotechnol J"},{"issue":"20","key":"16137_CR42","doi-asserted-by":"publisher","first-page":"11239","DOI":"10.3390\/ijms222011239","volume":"22","author":"W-J Leu","year":"2021","unstructured":"Leu W-J, Chang H-S, Chen I-S, Guh J-H, Chan S-H. Antileukemic Natural Product Induced Both Apoptotic and Pyroptotic Programmed Cell Death and Differentiation Effect. Int J Mol Sci. 2021;22(20):11239.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16137_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2022.2058862","volume":"23","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Kong Y, Jiang M, Kuang L, Wan J, Liu S, et al. Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines. Cancer Biol Ther. 2022;23(1):328\u201335.","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"16137_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14715\/cmb\/2023.69.7.21","volume":"69","author":"J Liu","year":"2023","unstructured":"Liu J, Gao W, Sheng Y, Sun J, Wen D. Resveratrol drives ferroptosis of acute myeloid leukemia cells through Hsa-miR-335-5p\/NFS1\/ GPX4 pathway in a ROS-dependent manner. Cell Mol Biol (Noisy-le-grand). 2023;69(7):131\u20137.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"3","key":"16137_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.chembiol.2017.12.013","volume":"25","author":"MC Okondo","year":"2018","unstructured":"Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, et al. Inhibition of Dpp8\/9 Activates the Nlrp1b Inflammasome. Cell Chem Biology. 2018;25(3):262\u2013e75.","journal-title":"Cell Chem Biology"},{"issue":"8","key":"16137_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41419-020-02865-4","volume":"11","author":"DC Johnson","year":"2020","unstructured":"Johnson DC, Okondo MC, Orth EL, Rao SD, Huang H-C, Ball DP, et al. DPP8\/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes. Cell Death Dis. 2020;11(8):628.","journal-title":"Cell Death Dis"},{"issue":"8","key":"16137_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","volume":"24","author":"DC Johnson","year":"2018","unstructured":"Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, et al. DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24(8):1151\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"16137_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F, Pyroptosis. Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem Sci. 2017;42(4):245\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"26","key":"16137_CR49","doi-asserted-by":"publisher","first-page":"eaat2738","DOI":"10.1126\/sciimmunol.aat2738","volume":"3","author":"JK Rathkey","year":"2018","unstructured":"Rathkey JK, Zhao J, Liu Z, Chen Y, Yang J, Kondolf HC, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018;3(26):eaat2738.","journal-title":"Sci Immunol"},{"issue":"7682","key":"16137_CR50","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017;551(7682):639\u201343.","journal-title":"Nature"},{"issue":"7784","key":"16137_CR51","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"7784","key":"16137_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138.","journal-title":"Nature"},{"issue":"4","key":"16137_CR53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.molcel.2020.10.016","volume":"80","author":"VO Sviderskiy","year":"2020","unstructured":"Sviderskiy VO, Blumenberg L, Gorodetsky E, Karakousi TR, Hirsh N, Alvarez SW, et al. Hyperactive CDK2 activity in basal-like breast cancer imposes a genome integrity liability that can be exploited by targeting DNA polymerase \u03b5. Mol Cell. 2020;80(4):682\u201398. e7.","journal-title":"Mol Cell"},{"issue":"2","key":"16137_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1751-2980.12576","volume":"19","author":"WJ Wang","year":"2018","unstructured":"Wang WJ, Chen D, Jiang MZ, XU B, Li XW, Chu Y, et al. Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J Dig Dis. 2018;19(2):74\u201383.","journal-title":"J Dig Dis"},{"issue":"4","key":"16137_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/carcin\/bgad005","volume":"44","author":"S Tanaka","year":"2023","unstructured":"Tanaka S, Orita H, Kataoka T, Miyazaki M, Saeki H, Wada R, et al. Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis. Carcinogenesis. 2023;44(4):341\u20139.","journal-title":"Carcinogenesis"},{"issue":"4","key":"16137_CR56","first-page":"1971","volume":"40","author":"J Gao","year":"2018","unstructured":"Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T, et al. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR\/Akt signaling and predicts a good prognosis in non\u2013small cell lung cancer. Oncol Rep. 2018;40(4):1971\u201384.","journal-title":"Oncol Rep"},{"key":"16137_CR57","doi-asserted-by":"publisher","first-page":"770005","DOI":"10.3389\/fonc.2022.770005","volume":"12","author":"L Li","year":"2022","unstructured":"Li L, Deng Z, Xiao Z, Zou W, Liu R. Analysis of pyroptosis-related signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. Front Oncol. 2022;12:770005.","journal-title":"Front Oncol"},{"issue":"4","key":"16137_CR58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group. Br J Haematol. 1976;33(4):451\u20138.","journal-title":"Br J Haematol"},{"issue":"6","key":"16137_CR59","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1182\/blood-2005-11-025536","volume":"109","author":"D Barbaric","year":"2006","unstructured":"Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, et al. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children\u2019s Oncology Group, studies CCG-2891 and CCG-2961. Blood. 2006;109(6):2314\u201321.","journal-title":"Blood"},{"key":"16137_CR60","doi-asserted-by":"crossref","unstructured":"Lv Z, Wang J, Wang X, Mo M, Tang G, Xu H et al. Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer. Front Cell Dev Biology. 2021;9:666025.","DOI":"10.3389\/fcell.2021.666025"},{"issue":"1","key":"16137_CR61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41392-022-00889-0","volume":"7","author":"J-F Lin","year":"2022","unstructured":"Lin J-F, Hu P-S, Wang Y-Y, Tan Y-T, Yu K, Liao K, et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct Target Therapy. 2022;7(1):54.","journal-title":"Signal Transduct Target Therapy"},{"key":"16137_CR62","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.2147\/JIR.S338584","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, Kang Y, Li Y, Sun L, Zhang J, Qian S, et al. Gasdermin D in different subcellular locations predicts diverse progression, immune microenvironment and prognosis in colorectal cancer. J Inflamm Res. 2021;14:6223\u201335.","journal-title":"J Inflamm Res"},{"issue":"2","key":"16137_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1124\/mol.105.013383","volume":"68","author":"X Xu","year":"2005","unstructured":"Xu X, Persson HL, Richardson DR. Molecular Pharmacology of the Interaction of Anthracyclines with Iron. Mol Pharmacol. 2005;68(2):261.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"16137_CR64","doi-asserted-by":"publisher","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549.","journal-title":"Mol Cell Oncol"},{"issue":"5","key":"16137_CR65","doi-asserted-by":"publisher","first-page":"e12663","DOI":"10.1111\/cpr.12663","volume":"52","author":"FY Mai","year":"2019","unstructured":"Mai FY, He P, Ye JZ, Xu LH, Ouyang DY, Li CG, et al. Caspase-3\u2010mediated GSDME activation contributes to cisplatin\u2010and doxorubicin\u2010induced secondary necrosis in mouse macrophages. Cell Prolif. 2019;52(5):e12663.","journal-title":"Cell Prolif"},{"issue":"2","key":"16137_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-021-03458-5","volume":"12","author":"X Shen","year":"2021","unstructured":"Shen X, Wang H, Weng C, Jiang H, Chen J. Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis. 2021;12(2):186.","journal-title":"Cell Death Dis"},{"issue":"10","key":"16137_CR67","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang C-W, You Y, Hsu J-M, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22(10):1264\u201375.","journal-title":"Nat Cell Biol"},{"issue":"17","key":"16137_CR68","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1111\/jcmm.16574","volume":"25","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang H, Li D, Zhou X, Qin Q, Zhang Q. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS\/JNK signalling pathway. J Cell Mol Med. 2021;25(17):8159\u201368.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"16137_CR69","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/biom13060904","volume":"13","author":"M Li","year":"2023","unstructured":"Li M, Jiang P, Wei S, Yang Y, Xiong L, Wang J, et al. Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment. Biomolecules. 2023;13(6):904.","journal-title":"Biomolecules"},{"issue":"12","key":"16137_CR70","first-page":"3149","volume":"13","author":"R Lin","year":"2020","unstructured":"Lin R, Wei H, Wang S, Huang Z, Chen H, Zhang S, et al. Gasdermin D expression and clinicopathologic outcome in primary osteosarcoma patients. Int J Clin Exp Pathol. 2020;13(12):3149\u201357.","journal-title":"Int J Clin Exp Pathol"},{"issue":"40","key":"16137_CR71","doi-asserted-by":"publisher","first-page":"e35440","DOI":"10.1097\/MD.0000000000035440","volume":"102","author":"L Wu","year":"2023","unstructured":"Wu L, Wu X, Liu J, Huang Y, Zhu Q. Expression and significance of effector proteins NLRP3 and gasdermin D N-terminal protein in the pyrolysis pathway in breast cancer. Medicine. 2023;102(40):e35440.","journal-title":"Medicine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16137-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:08:11Z","timestamp":1781064491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16137-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16137"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16137-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted in compliance with the Declaration of Helsinki and was approved by the Ethical Committee of Research at the Faculty of Medicine, Ain Shams University, operating under the federal wide assurance number FWA 000017585. Written informed consent was provided by all participants prior to the study start.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"739"}}